ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,659.43
      1.33%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      02/10/201111:47AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20116:00AMPR Newswire (US)Lexicon Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/31/201112:28PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/28/20115:31PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/28/20114:42PMEdgar (US Regulatory)Withdrawal of Registration Statement (RW)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/07/20116:50AMGlobeNewswire Inc.Lexicon Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/06/20116:00AMPR Newswire (US)Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes PatientsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/04/20116:00PMPR Newswire (US)Lexicon Pharmaceuticals to Present at the 29th Annual JPMorgan Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/14/20106:50AMPR Newswire (US)Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid ArthritisNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/30/20109:00AMPR Newswire (US)Lexicon Pharmaceuticals to Present at 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/08/20105:16PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/05/20108:24AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/05/20107:00AMPR Newswire (US)Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/26/20106:00PMPR Newswire (US)Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/12/20106:00PMPR Newswire (US)Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22ndNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/09/20108:19AMPR Newswire (US)Lexicon to Present at Stifel Nicolaus Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/07/20108:00AMPR Newswire (US)Lexicon to Present at Morgan Stanley Global Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20104:41PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20104:38PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20108:12AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20108:11AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20106:30AMPR Newswire (US)Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Second Quarter Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/03/20106:30PMPR Newswire (US)Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/02/20104:15PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/02/20106:30AMPR Newswire (US)Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon ProgramsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/28/20109:53AMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/21/20106:00PMPR Newswire (US)Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/15/20107:00PMPR Newswire (US)Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare ConferencesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/03/20106:18PMPR Newswire (US)Lexicon to Present at Two Major Healthcare Investor ConferencesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/19/20105:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX